DE69315989T2 - Aminoterminale prokollagen 1(i) peptide - Google Patents

Aminoterminale prokollagen 1(i) peptide

Info

Publication number
DE69315989T2
DE69315989T2 DE69315989T DE69315989T DE69315989T2 DE 69315989 T2 DE69315989 T2 DE 69315989T2 DE 69315989 T DE69315989 T DE 69315989T DE 69315989 T DE69315989 T DE 69315989T DE 69315989 T2 DE69315989 T2 DE 69315989T2
Authority
DE
Germany
Prior art keywords
epitopes
peptide
peptides
antibodies
aminoterminal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69315989T
Other languages
English (en)
Other versions
DE69315989D1 (de
Inventor
David Jeston Baylink
Susan Linkhart
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of DE69315989D1 publication Critical patent/DE69315989D1/de
Application granted granted Critical
Publication of DE69315989T2 publication Critical patent/DE69315989T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Cell Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Zoology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
DE69315989T 1992-01-31 1993-01-25 Aminoterminale prokollagen 1(i) peptide Expired - Fee Related DE69315989T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US82914292A 1992-01-31 1992-01-31
PCT/US1993/000643 WO1993015107A1 (en) 1992-01-31 1993-01-25 Amino procollagen 1(i) peptides

Publications (2)

Publication Number Publication Date
DE69315989D1 DE69315989D1 (de) 1998-02-05
DE69315989T2 true DE69315989T2 (de) 1998-04-23

Family

ID=25253645

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69315989T Expired - Fee Related DE69315989T2 (de) 1992-01-31 1993-01-25 Aminoterminale prokollagen 1(i) peptide

Country Status (7)

Country Link
US (1) US5599679A (de)
EP (1) EP0631586B1 (de)
JP (1) JPH07504896A (de)
AT (1) ATE161543T1 (de)
CA (1) CA2128877A1 (de)
DE (1) DE69315989T2 (de)
WO (1) WO1993015107A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4225038C2 (de) * 1992-07-29 1995-11-30 Boehringer Mannheim Gmbh Herstellung und Verwendung von Antikörpern gegen Kollagen
WO1995004282A1 (de) * 1993-07-28 1995-02-09 Boehringer Mannheim Gmbh Immunoassay zum nachweis von kollagen oder kollagenfragmenten
DK104093D0 (da) * 1993-09-17 1993-09-17 Osteometer A S Fremgangsmaade til bestemmelse af collagen-fragmenter i legemsvaesker, test-kit og midler til udoevelse af fremgangsmaaden og anvendelse af fremgangsmaaden til diagnosticering af lidelser associeret til collagen-metabolismen
GB9507985D0 (en) * 1995-04-19 1995-06-07 Orion Yhtymae Oy Antibody to aminoterminal propeptide to type 1 procollagen and assay method using it
AUPP547398A0 (en) * 1998-08-26 1998-09-17 Medvet Science Pty. Ltd. Predictive assessment of certain skeletal disorders
ATE370971T1 (de) * 1999-12-13 2007-09-15 Univ Mexico Nacional Autonoma Quantitative immunoenzymatische messmethode
US20100206392A1 (en) * 2009-02-18 2010-08-19 Wcm Industries, Inc. Automatic Draining Freezeless Wall Faucet
RU2628370C2 (ru) * 2015-12-28 2017-08-16 Федеральное государственное бюджетное учреждение "Центральный научно-исследовательский институт травматологии и ортопедии имени Н.Н. Приорова" Министерства здравоохранения Российской Федерации (ФГБУ "ЦИТО им. Н.Н. Приорова" Минздрава России) Способ хирургического лечения гетеротопической оссификации с выполнением локального нейромоделирования спастического синдрома пациента
CN115490768A (zh) * 2021-06-18 2022-12-20 佛山热休生物技术有限公司 Col1a1的表位肽及所述表位肽与热休克蛋白的复合物

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2208865B (en) * 1987-08-19 1991-12-11 Farmos Group Ltd Purified propeptide of procollagen type iii, antibody to the propeptide and assay method using the antibody.

Also Published As

Publication number Publication date
EP0631586A1 (de) 1995-01-04
US5599679A (en) 1997-02-04
DE69315989D1 (de) 1998-02-05
EP0631586A4 (de) 1995-08-02
JPH07504896A (ja) 1995-06-01
WO1993015107A1 (en) 1993-08-05
EP0631586B1 (de) 1997-12-29
CA2128877A1 (en) 1993-08-05
ATE161543T1 (de) 1998-01-15

Similar Documents

Publication Publication Date Title
KR970702917A (ko) Lag-3의 가용성 폴리펩타이드 절편 및 생산 방법, 치료 조성물, 항-이디오타입 항체
PT82132B (pt) Polipeptidos complementares para peptidos ou proteinas que tem uma sequencia de aminoacidos ou uma sequencia codificadora de nucleotidos pelos menos parcialmente conhecidas
EA200100447A1 (ru) Гибридные белки на основе бета-интерферона и их применение
DE69228701T2 (de) Fragmente von Prion Proteinen.
ATE368053T1 (de) Antimikrobielle peptide
DE69535948D1 (de) Von wd-40 abstammende peptide und ihre verwendung
DK0479948T3 (da) Sammensætninger og fremgangsmåder til syntese af natriuretisk protein-receptor B og anvendelsesfremgangsmåder
DE69939327D1 (de) Funktionelle antagonisten von hedgehog-aktivität
ES2044950T3 (es) Un procedimiento para producir una proteina.
YU79491A (sh) Varijantni cd44-površinski proteini, dna-sekvence koje ih kodiraju i antitela protiv ovih proteina
ATE197307T1 (de) Neuroaktive peptide
ATE177758T1 (de) Synthetische peptide, antikörper dagegen und ihre verwendung
DK1129186T3 (da) Et faktor VIII-polypeptid med faktor VIII:C-aktivitet
DE69315989D1 (de) Aminoterminale prokollagen 1(i) peptide
ATE327328T1 (de) Adipozyten-spezifische protein homologe
DE68925199T2 (de) Peptide und polypeptide stammend von den submaxillaren drüsen der ratte, deren entsprechende monoklonale und polyklonale antikörper entsprechende hybridomen und verwendung dieser verbindungen in der diagnose bei bestimmungen und für pharmazeutische zwecke
DE68925275D1 (de) Endotoxin-bindeprotein und dessen verwendung
ATE360695T1 (de) Cortistatin: neuropeptide, zusammensetzungen und methoden
TW272197B (de)
DE69333952D1 (de) Klonering von dem gen für das t gondii protein gp 28.5 peptidfragmente aus diesem protein und ihre verwendungen.
PT639225E (pt) Polipeptidos e peptidos novos acidos nucleicos que codificam para aqueles e sua utilizacao na area da terapia tumoral inflamacao ou imunologia
ATE294816T1 (de) Neue, physiologisch aktive peptide und ihre verwendung.
PT723552E (pt) Oligopeptidos derivados de fragmentos de proteina reactiva c
DE59814002D1 (de) Sekretion von tragergebundenen proteinen in das periplasma und in den extrazellulären raum
DE59608073D1 (de) Antikörper gegen ein, einen histidin-anteil aufweisendes fusionspolypeptid

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee